An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene

H. S. Kim, S. M. Kim, S. W. Kang, S. C. Jung, K. S. Lee, T. S. Kim, Young Chul Choi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We report a patient with familial amyloid polyneuropathy. Gene analysis revealed a heterozygous Glu54Gly substitution (A-to-G change) in the transthyretin gene. This is the first case of a Glu54Gly substitution that was devoid of a Gly6Ser substitution. Compared with the previously reported case with compound heterozygotes of Glu54Gly and Gly6Ser, the age of onset in our case is much younger and another characteristic findings were the amyloid vasculopathy and the multiple organ involvement. A Glu54Gly mutation is amyloidogenic by itself and a Gly6Ser mutation may offer some protection from the Glu54Gly mutant.

Original languageEnglish
Pages (from-to)657-659
Number of pages3
JournalEuropean Journal of Neurology
Volume12
Issue number8
DOIs
Publication statusPublished - 2005 Aug 1

Fingerprint

Familial Amyloid Neuropathies
Prealbumin
Mutation
Heterozygote
Age of Onset
Amyloid
Genes

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Kim, H. S. ; Kim, S. M. ; Kang, S. W. ; Jung, S. C. ; Lee, K. S. ; Kim, T. S. ; Choi, Young Chul. / An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene. In: European Journal of Neurology. 2005 ; Vol. 12, No. 8. pp. 657-659.
@article{6e752583214146758993a38ff604154e,
title = "An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene",
abstract = "We report a patient with familial amyloid polyneuropathy. Gene analysis revealed a heterozygous Glu54Gly substitution (A-to-G change) in the transthyretin gene. This is the first case of a Glu54Gly substitution that was devoid of a Gly6Ser substitution. Compared with the previously reported case with compound heterozygotes of Glu54Gly and Gly6Ser, the age of onset in our case is much younger and another characteristic findings were the amyloid vasculopathy and the multiple organ involvement. A Glu54Gly mutation is amyloidogenic by itself and a Gly6Ser mutation may offer some protection from the Glu54Gly mutant.",
author = "Kim, {H. S.} and Kim, {S. M.} and Kang, {S. W.} and Jung, {S. C.} and Lee, {K. S.} and Kim, {T. S.} and Choi, {Young Chul}",
year = "2005",
month = "8",
day = "1",
doi = "10.1111/j.1468-1331.2005.01005.x",
language = "English",
volume = "12",
pages = "657--659",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "8",

}

An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene. / Kim, H. S.; Kim, S. M.; Kang, S. W.; Jung, S. C.; Lee, K. S.; Kim, T. S.; Choi, Young Chul.

In: European Journal of Neurology, Vol. 12, No. 8, 01.08.2005, p. 657-659.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene

AU - Kim, H. S.

AU - Kim, S. M.

AU - Kang, S. W.

AU - Jung, S. C.

AU - Lee, K. S.

AU - Kim, T. S.

AU - Choi, Young Chul

PY - 2005/8/1

Y1 - 2005/8/1

N2 - We report a patient with familial amyloid polyneuropathy. Gene analysis revealed a heterozygous Glu54Gly substitution (A-to-G change) in the transthyretin gene. This is the first case of a Glu54Gly substitution that was devoid of a Gly6Ser substitution. Compared with the previously reported case with compound heterozygotes of Glu54Gly and Gly6Ser, the age of onset in our case is much younger and another characteristic findings were the amyloid vasculopathy and the multiple organ involvement. A Glu54Gly mutation is amyloidogenic by itself and a Gly6Ser mutation may offer some protection from the Glu54Gly mutant.

AB - We report a patient with familial amyloid polyneuropathy. Gene analysis revealed a heterozygous Glu54Gly substitution (A-to-G change) in the transthyretin gene. This is the first case of a Glu54Gly substitution that was devoid of a Gly6Ser substitution. Compared with the previously reported case with compound heterozygotes of Glu54Gly and Gly6Ser, the age of onset in our case is much younger and another characteristic findings were the amyloid vasculopathy and the multiple organ involvement. A Glu54Gly mutation is amyloidogenic by itself and a Gly6Ser mutation may offer some protection from the Glu54Gly mutant.

UR - http://www.scopus.com/inward/record.url?scp=23644453659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644453659&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2005.01005.x

DO - 10.1111/j.1468-1331.2005.01005.x

M3 - Article

C2 - 16053476

AN - SCOPUS:23644453659

VL - 12

SP - 657

EP - 659

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 8

ER -